Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.

European heart journal. Cardiovascular Imaging2019Kitkungvan D, Bui L, Johnson NP, et al.

Study designRandomized controlled trial

SubjectHuman

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AdenosineAdenosine A2 Receptor AgonistsAgedCaffeineCardiovascular DiseasesCoronary CirculationDipyridamoleExercise TestFemaleHumansMaleMiddle AgedMyocardial Perfusion ImagingPositron-Emission TomographyPurinesPyrazoles

DOI 10.1093/ehjci/jez080

PMID 31056681

View source →